Circular Genomics Joins Lilly Gateway Labs in San Diego to Develop Its Best-In-Class Circular RNA Platform for the Diagnosis and Prognosis of Alzheimer’s Disease

Circular Genomics’ move to the Lilly Gateway Labs community will enhance scientific collaboration and innovation to foster the development of its Alzheimer’s disease diagnostic and prognostic blood tests SAN DIEGO, March 17, 2025 /PRNewswire/ — Circular Genomics, a global leader in…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.